{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:16Z","timestamp":1759366456653,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.revmed.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T02:35:11Z","timestamp":1604284511000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u00c9tude observationnelle de l\u2019usage du QuantiFERON\u00ae pour le diagnostic de tuberculose oculaire, bas\u00e9e sur 244\u00a0tests cons\u00e9cutifs"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Amara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ben Salah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guihot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fardeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Touitoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-9180","authenticated-orcid":false,"given":"S","family":"Trad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2020.09.005_bib0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/eye.2009.51","article-title":"The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs","volume":"24","author":"Cordero-Coma","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.revmed.2020.09.005_bib0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/09273948.2014.986584","article-title":"The role of anti-tubercular therapy in patients with presumed ocular tuberculosis","volume":"23","author":"Agrawal","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12886-017-0597-x","article-title":"What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis","volume":"17","author":"Agrawal","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0195","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","article-title":"Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis","volume":"157","author":"La Distia Nora","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0200","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/09273948.2013.866255","article-title":"Three years of experience with QuantiFERON-TB gold testing in patients with uveitis","volume":"22","author":"Jakob","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajo.2008.06.021","article-title":"Interferon-gamma release assays in the diagnosis of tuberculous uveitis","volume":"146","author":"Albini","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2019.11.009","article-title":"Prevalence of positive QuantiFERON-TB gold in-tube test in uveitis and its clinical implications in a country nonendemic for tuberculosis","volume":"211","author":"Groen-Hakan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0215","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","article-title":"Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis","volume":"146","author":"Bansal","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/eye.2010.235","article-title":"Presumed tuberculous uveitis: diagnosis, management, and outcome","volume":"25","author":"Sanghvi","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.revmed.2020.09.005_bib0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/09273948.2014.967358","article-title":"Classification of intraocular tuberculosis","volume":"23","author":"Gupta","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0230","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/09273948.2017.1332232","article-title":"Update on Immunological Test (Quantiferon-TB Gold) contribution in the management of tuberculosis-related ocular inflammation","volume":"26","author":"Trad","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0235","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","article-title":"Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study","volume":"96","author":"Ang","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0245","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","article-title":"Ocular signs predictive of tubercular uveitis","volume":"149","author":"Gupta","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-9394(98)00325-0","article-title":"Indocyanine green angiographic features in tuberculous chorioretinitis","volume":"127","author":"Wolfensberger","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0255","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bjophthalmol-2013-303937","article-title":"The utility of routine tuberculosis screening in county hospital patients with uveitis","volume":"98","author":"Hong","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ajo.2011.02.006","article-title":"QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation","volume":"152","author":"Gineys","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0265","first-page":"498","article-title":"Review of results of QuantiFERON TB gold test in presumed ocular tuberculosis in a South Indian patient population","volume":"24","author":"Babu","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0270","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/eye.2012.1","article-title":"Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis","volume":"26","author":"Ang","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.revmed.2020.09.005_bib0275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/eye.2013.5","article-title":"Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a high-endemic setting","volume":"27","author":"Basu","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.revmed.2020.09.005_bib0280","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ajo.2011.05.004","article-title":"Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment","volume":"152","author":"Gupta","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0285","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bjophthalmol-2014-306474","article-title":"Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence","volume":"100","author":"Agrawal","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0290","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/0301-4738.57147","article-title":"Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation","volume":"57","author":"Babu","year":"2009","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0295","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","article-title":"Intraocular tuberculosis \u2013 an update","volume":"52","author":"Gupta","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0300","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.revmed.2018.02.022","article-title":"Les manifestations oculaires de la maladie de Beh\u00e7et","volume":"39","author":"Desbois","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2020.09.005_bib0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.iio.0000155935.60213.ac","article-title":"Ocular tuberculosis: anterior segment","volume":"45","author":"Tabbara","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.revmed.2020.09.005_bib0310","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2020.09.005_bib0315","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ophtha.2009.02.005","article-title":"Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay","volume":"116","author":"Ang","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2020.09.005_bib0320","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/bjophthalmol-2014-305229","article-title":"Discordance of two interferon-\u03b3 release assays and tuberculin skin test in patients with uveitis","volume":"98","author":"Ang","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2020.09.005_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2020.06.019","article-title":"Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT. TB among patients with tuberculosis","author":"Takeda","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.revmed.2020.09.005_bib0330","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of Serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2020.09.005_bib0335","article-title":"Collaborative Ocular Tuberculosis Study (COTS) consensus guidelines on the management of tubercular uveitis \u2013 report 2: guidelines for initiating anti-tubercular therapy in anterior uveitis, intermediate uveitis, panuveitis and retinal vasculitis","author":"Agrawal","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2020.09.005_bib0340","first-page":"1","article-title":"The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 165\u00a0patients with tubercular anterior uveitis","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0345","first-page":"1","article-title":"Standardization of nomenclature for ocular tuberculosis \u2013 results of Collaborative Ocular Tuberculosis Study (COTS) workshop","volume":"10","author":"Agrawal","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2020.09.005_bib0175","article-title":"Twenty-four month outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: defining the \u201cCure\u201d in ocular tuberculosis","author":"Agrawal","year":"2019","journal-title":"Ocul Immunol Inflamm"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320303751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320303751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:42:50Z","timestamp":1759336970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866320303751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0248866320303751"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.09.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tude observationnelle de l\u2019usage du QuantiFERON\u00ae pour le diagnostic de tuberculose oculaire, bas\u00e9e sur 244\u00a0tests cons\u00e9cutifs","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}